/SVRA

Savara Inc

SVRA

$5.30USD↓-0.38%-0.02 today

MARKET CAP

1.1B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$5 – $5

52W RANGE

$3

$7

AI Summary

Stalk

StalkMedium

The stock remains in a secular uptrend as 50- and 200-day SMAs slope higher, but short-term price is choppy between EMAs with neutral momentum. Medium-term bias is bullish on support near the 50-day SMA around $5.50–$5.60, yet entries should be deferred until a pullback into that area and confirmed acceptance off moving-average support rather than chasing the current consolidation near $5.75.

↑Phase 3 molgramostim data from IMPALA-2 suggests FDA approval
↑$10.94 target price implies ~97% upside potential
↓Negative earnings yield and weak profitability factors raise survival doubts

Full analysis →

Buying

3

institutions

Selling

9

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	12.49 M	76.97 M	+1.20 M	+24.8%	0.00%
WP Woodline Partners LP Q2 2026	SELL	4.25 M	26.15 M	+-4.25 M	-43.6%	0.08%
AC Adar1 Capital Management, LLC Q2 2026	SELL	1.40 M	8.64 M	+-61.13 K	+8.1%	0.40%
CA Citadel Advisors LLC Q2 2026	SELL	338.05 K	2.08 M	+-474.89 K	-53.1%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	248.89 K	1.53 M	+-403.78 K	-57.0%	0.00%
EP Eversept Partners, LP Q2 2026	SELL	204.43 K	1.26 M	+-179.84 K	-40.0%	0.07%
JC Jpmorgan Chase & Co Q2 2026	BUY	85.91 K	518.03 K	+5.20 K	+27.1%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUYNEW	90.40 K	494.04 K	+90.40 K	+0.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	40.24 K	247.89 K	+-14.94 K	-17.7%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-463.00 K	-100.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-40.02 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-36.58 K	-100.0%	0.00%